Items 1 ~ 8 of 23, Page 1 of 3
WHO highlights scarcity of treatment for epilepsy in low-income countries
Premature death is three times higher in people with epilepsy / Stigma is widespread / Treatment for epilepsy can be integrated into primary health se...
AMA: Senate HELP Bill on surprise billing fails to fix a broken system
American Medical Association (AMA)
Reports of Eye Injuries From Fireworks Have Doubled
American Academy of Ophthalmology offers tips on how to stay safe around fireworks
American Academy of Ophthalmology
Merck Hosts 2019 Investor Day Outlining Business Momentum, Strong Expected Growth and Focus on Innovative Research and Development
WHO flags critical funding gap, calls for political parties to join fight against Ebola
WHO Director-General briefs Members States on situation in DRC and appeals for funding for the Ebola response
AstraZeneca and Merck’s LYNPARZA® (olaparib) Approved in Japan as First-Line Maintenance Therapy in Patients with BRCA-Mutated Advanced Ovarian Cancer
LYNPARZA is the Only PARP Inhibitor Approved in Japan
In the face of slow progress, WHO offers a new tool and sets a target to accelerate action against antimicrobial resistance
1 in 3 people globally do not have access to safe drinking water ? UNICEF, WHO
New report on inequalities in access to water, sanitation and hygiene also reveals more than half of the world does not have access to safe sanitation...